Amgen Inc.AMGNNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+14.0%
5Y CAGR+8.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+14.0%/yr
vs +2.5%/yr prior
5Y CAGR
+8.7%/yr
Recent acceleration
Acceleration
+11.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $15.34B | +15.2% |
| 2024 | $13.31B | +12.4% |
| 2023 | $11.84B | +14.4% |
| 2022 | $10.35B | -12.9% |
| 2021 | $11.89B | +17.4% |
| 2020 | $10.13B | +8.5% |
| 2019 | $9.33B | -0.5% |
| 2018 | $9.38B | +6.5% |
| 2017 | $8.81B | -2.5% |
| 2016 | $9.04B | - |